On April 7, 2026, the US Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) announced a notice of proposed rulemaking ...

Fast track status supports expedited development/review for a serious hematologic malignancy with limited second-line therapy after HMA failure. CyTAC engineering merges small-molecule CCR2 binding ...

The CEO said positive Regal data could potentially help GPS gain broader NCCN recognition beyond the current AML setting. ・Earlier GPS data showed median survival of 35.5 months in older AML patients ...

Concomitant systemic mastocytosis (SM) can complicate acute myeloid leukaemia (AML) with t(8;21) and its recognition, particularly in the presence of KIT D816 mutations, according ...

Sellas recently said its late-stage Regal trial of GPS in AML is only two events away from reaching the topline data readout stage. ・For the first quarter, Sellas’ net loss widened largely due to ...

Every sanctions team I speak to quotes a false-positive rate above 95 per cent as if it were weather. That number is not a ...

Oral presentation will highlight favorable outcomes observed among 21 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who ...

Justice Bean described the firms costs as "enormous" for a trial which lasted one day in the High Court and two days in the ...

Investigators evaluated children with acute lymphoblastic or acute myeloid leukemia to identify racial/ethnic and neighborhood disparities in acute kidney injury.

Kebbeh Harris Dolo and Massa Senesie are two female employees of ArcelorMittal Liberia (AML) serving as Wheel Loader ...

Early blinded results show 40% composite complete remission rate across difficult-to-treat AML patient population in MIRACLE TrialFirst interim ...

On May 13, the Food and Drug Administration (FDA) approved decitabine and cedazuridine (Inqovi) tablets in combination with venetoclax (Venclexta) for adults newly diagnosed with AML who are aged 75 ...